SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-21-001673
Filing Date
2021-11-23
Accepted
2021-11-23 09:23:35
Documents
8
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K medicure6k.htm 6-K 13345
2 Q3 FINANCIAL STATEMENTS ex991.htm EX-99.1 329491
3 Q3 MD&A ex992.htm EX-99.2 291874
4 CEO CERTIFICATION ex993.htm EX-99.3 5852
5 CFO CERTIFICATION ex994.htm EX-99.4 5835
6 GRAPHIC logo.jpg GRAPHIC 16359
7 GRAPHIC logo_small.jpg GRAPHIC 6504
8 GRAPHIC mda_sig.jpg GRAPHIC 8999
  Complete submission text file 0001279569-21-001673.txt   691662
Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31995 | Film No.: 211435116
SIC: 2834 Pharmaceutical Preparations